{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:22:27Z","timestamp":1790670147809,"version":"4.1.0"},"reference-count":40,"publisher":"National Academy of Sciences","issue":"32","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK018849-41"],"award-info":[{"award-number":["DK018849-41"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK018024-43"],"award-info":[{"award-number":["DK018024-43"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000983","name":"Mary Kay Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA009523"],"award-info":[{"award-number":["CA009523"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["31671391"],"award-info":[{"award-number":["31671391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Natural Science Foundation","doi-asserted-by":"crossref","award":["LR18C050001"],"award-info":[{"award-number":["LR18C050001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development program of China","doi-asserted-by":"crossref","award":["2017YFA0505200"],"award-info":[{"award-number":["2017YFA0505200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development program of China","doi-asserted-by":"crossref","award":["2016YFC0906000"],"award-info":[{"award-number":["2016YFC0906000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2018,8,7]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Curcumin is an ancient drug derived from turmeric and has been found to exhibit potent anticancer properties albeit through controversial mechanisms of action. Using a biochemical model, mouse cancer model, and cellular models, we show that curcumin is a highly potent and selective inhibitor of dual-specificity tyrosine-regulated kinase 2 (DYRK2), a positive regulator of the 26S proteasome. Curcumin perturbs 26S proteasome activity via DYRK2 inhibition in various cancer cells and in the mouse cancer model leading to impairment of cell proliferation and reduction of cancer burden in mice. This novel mechanism of action of curcumin opens up new avenues for potential preventative or therapeutic strategies in proteasome-addicted cancers like triple-negative breast cancer and multiple myeloma.<\/jats:p>","DOI":"10.1073\/pnas.1806797115","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T15:18:05Z","timestamp":1531149485000},"page":"8155-8160","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":164,"title":["Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2"],"prefix":"10.1073","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-2989","authenticated-orcid":false,"given":"Sourav","family":"Banerjee","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0721;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggong","family":"Ji","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Mayfield","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0721;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apollina","family":"Goel","sequence":"additional","affiliation":[{"name":"Division of the Department of Radiation Oncology, The University of Iowa, Iowa City, IA 52242-1181;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-1701","authenticated-orcid":false,"given":"Junyu","family":"Xiao","sequence":"additional","affiliation":[{"name":"The State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, 100871 Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack E.","family":"Dixon","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0721;"},{"name":"Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093;"},{"name":"Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[{"name":"The Life Sciences Institute, Zhejiang University, 310058 Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-46401-5_1","article-title":"Curcumin: The Indian solid gold","volume":"595","author":"Aggarwal BB","year":"2007","unstructured":"BB Aggarwal, C Sundaram, N Malani, H Ichikawa, Curcumin: The Indian solid gold. Adv Exp Med Biol 595, 1\u201375 (2007).","journal-title":"Adv Exp Med Biol"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fchem.2014.00113","article-title":"Farmer to pharmacist: Curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer","volume":"2","author":"Bandyopadhyay D","year":"2014","unstructured":"D Bandyopadhyay, Farmer to pharmacist: Curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer. Front Chem 2, 113 (2014).","journal-title":"Front Chem"},{"key":"e_1_3_4_3_2","first-page":"1","volume-title":"Diss Inaug Halae","author":"Loeber CC","year":"1748","unstructured":"CC Loeber, AE Buechner, Dissertatio inauguralis medica de curcuma officinarum ejusque genuinis virtutibus [Scientific dissertation on the real medicinal virtues of the rhizomes of curcuma]. Diss Inaug Halae, eds Pr\u00e6s, AE B\u00fcchnero (HalaeMagdeburgicae, Halle, Germany), pp. 1\u201328 (1748)."},{"key":"e_1_3_4_4_2","first-page":"20","article-title":"Chemische Untersuchung der Gilbwurzel (Kurkume)","volume":"7","author":"Vogel HA","year":"1815","unstructured":"HA Vogel, J Pelletier, Chemische Untersuchung der Gilbwurzel (Kurkume). J Pharm (Cairo) 7, 20 (1815).","journal-title":"J Pharm (Cairo)"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(00)98193-5","article-title":"Turmeric (curcumin) in biliary diseases","volume":"229","author":"Oppenheimer A","year":"1937","unstructured":"A Oppenheimer, Turmeric (curcumin) in biliary diseases. Lancet 229, 619\u2013621 (1937).","journal-title":"Lancet"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","author":"Nelson KM","year":"2017","unstructured":"KM Nelson, , The essential medicinal chemistry of curcumin. J Med Chem 60, 1620\u20131637 (2017).","journal-title":"J Med Chem"},{"key":"e_1_3_4_7_2","first-page":"363","article-title":"Anticancer potential of curcumin: Preclinical and clinical studies","volume":"23","author":"Aggarwal BB","year":"2003","unstructured":"BB Aggarwal, A Kumar, AC Bharti, Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23, 363\u2013398 (2003).","journal-title":"Anticancer Res"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane)","volume":"270","author":"Singh S","year":"1995","unstructured":"S Singh, BB Aggarwal, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270, 24995\u201325000, and erratum (1995) 270:30235 (1995).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","article-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","volume":"101","author":"Bharti AC","year":"2003","unstructured":"AC Bharti, N Donato, S Singh, BB Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053\u20131062 (2003).","journal-title":"Blood"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14756360802364377","article-title":"Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro\/in vivo evaluation","volume":"24","author":"Bustanji Y","year":"2009","unstructured":"Y Bustanji, , Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro\/in vivo evaluation. J Enzyme Inhib Med Chem 24, 771\u2013778 (2009).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/acs.jmedchem.5b01009","article-title":"Can invalid bioactives undermine natural product-based drug discovery?","volume":"59","author":"Bisson J","year":"2016","unstructured":"J Bisson, , Can invalid bioactives undermine natural product-based drug discovery? J Med Chem 59, 1671\u20131690 (2016).","journal-title":"J Med Chem"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","article-title":"Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice","volume":"11","author":"Aggarwal BB","year":"2005","unstructured":"BB Aggarwal, , Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490\u20137498 (2005).","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-06-4257","article-title":"Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products","volume":"67","author":"Kunnumakkara AB","year":"2007","unstructured":"AB Kunnumakkara, , Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67, 3853\u20133861 (2007).","journal-title":"Cancer Res"},{"key":"e_1_3_4_14_2","first-page":"597","article-title":"Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion\/progression stages of colon cancer","volume":"59","author":"Kawamori T","year":"1999","unstructured":"T Kawamori, , Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion\/progression stages of colon cancer. Cancer Res 59, 597\u2013601 (1999).","journal-title":"Cancer Res"},{"key":"e_1_3_4_15_2","first-page":"5841","article-title":"Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice","volume":"54","author":"Huang MT","year":"1994","unstructured":"MT Huang, , Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54, 5841\u20135847 (1994).","journal-title":"Cancer Res"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/emboj\/20.7.1630","article-title":"COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system","volume":"20","author":"Bech-Otschir D","year":"2001","unstructured":"D Bech-Otschir, , COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20, 1630\u20131639 (2001).","journal-title":"EMBO J"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"11680","DOI":"10.1074\/jbc.M310369200","article-title":"Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway","volume":"279","author":"Jana NR","year":"2004","unstructured":"NR Jana, P Dikshit, A Goswami, N Nukina, Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279, 11680\u201311685 (2004).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03033305","article-title":"Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function","volume":"9","author":"Dikshit P","year":"2006","unstructured":"P Dikshit, A Goswami, A Mishra, M Chatterjee, NR Jana, Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function. Neurotox Res 9, 29\u201337 (2006).","journal-title":"Neurotox Res"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JVI.02028-06","article-title":"Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication","volume":"81","author":"Si X","year":"2007","unstructured":"X Si, , Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol 81, 3142\u20133150 (2007).","journal-title":"J Virol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-007-0197-y","article-title":"The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs","volume":"85","author":"Neuss H","year":"2007","unstructured":"H Neuss, , The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs. J Mol Med (Berl) 85, 961\u2013970 (2007).","journal-title":"J Mol Med (Berl)"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1158\/0008-5472.CAN-07-6246","article-title":"Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo","volume":"68","author":"Milacic V","year":"2008","unstructured":"V Milacic, , Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res 68, 7283\u20137292 (2008).","journal-title":"Cancer Res"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1146\/annurev.bi.65.070196.004101","article-title":"Structure and functions of the 20S and 26S proteasomes","volume":"65","author":"Coux O","year":"1996","unstructured":"O Coux, K Tanaka, AL Goldberg, Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65, 801\u2013847 (1996).","journal-title":"Annu Rev Biochem"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","article-title":"The logic of the 26S proteasome","volume":"169","author":"Collins GA","year":"2017","unstructured":"GA Collins, AL Goldberg, The logic of the 26S proteasome. Cell 169, 792\u2013806 (2017).","journal-title":"Cell"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nature11468","article-title":"Increased proteasome activity in human embryonic stem cells is regulated by PSMD11","volume":"489","author":"Vilchez D","year":"2012","unstructured":"D Vilchez, , Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature 489, 304\u2013308 (2012).","journal-title":"Nature"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn C","year":"2013","unstructured":"C L\u00f3pez-Ot\u00edn, MA Blasco, L Partridge, M Serrano, G Kroemer, The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2011.03.017","article-title":"Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division","volume":"34","author":"Chang JT","year":"2011","unstructured":"JT Chang, , Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 34, 492\u2013504 (2011).","journal-title":"Immunity"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature07960","article-title":"Targeting the ubiquitin system in cancer therapy","volume":"458","author":"Hoeller D","year":"2009","unstructured":"D Hoeller, I Dikic, Targeting the ubiquitin system in cancer therapy. Nature 458, 438\u2013444 (2009).","journal-title":"Nature"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature11315","article-title":"RPN-6 determines C. elegans longevity under proteotoxic stress conditions","volume":"489","author":"Vilchez D","year":"2012","unstructured":"D Vilchez, , RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature 489, 263\u2013268 (2012).","journal-title":"Nature"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrn2499","article-title":"Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction","volume":"9","author":"Tai HC","year":"2008","unstructured":"HC Tai, EM Schuman, Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9, 826\u2013838 (2008).","journal-title":"Nat Rev Neurosci"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ccr.2013.07.008","article-title":"A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells","volume":"24","author":"Petrocca F","year":"2013","unstructured":"F Petrocca, , A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells. Cancer Cell 24, 182\u2013196 (2013).","journal-title":"Cancer Cell"},{"key":"e_1_3_4_31_2","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima T","year":"2001","unstructured":"T Hideshima, , The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61, 3071\u20133076 (2001).","journal-title":"Cancer Res"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson PG","year":"2003","unstructured":"PG Richardson, , A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348, 2609\u20132617 (2003).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","article-title":"Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma","volume":"110","author":"Kuhn DJ","year":"2007","unstructured":"DJ Kuhn, , Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood 110, 3281\u20133290 (2007).","journal-title":"Blood"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2014-01-548826","article-title":"Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed\/refractory multiple myeloma patients","volume":"124","author":"Richardson PG","year":"2014","unstructured":"PG Richardson, , Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed\/refractory multiple myeloma patients. Blood 124, 1038\u20131046 (2014).","journal-title":"Blood"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1038\/onc.2017.172","article-title":"Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"36","author":"Song Y","year":"2017","unstructured":"Y Song, , Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Oncogene 36, 5631\u20135638 (2017).","journal-title":"Oncogene"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nchembio.2326","article-title":"Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11","volume":"13","author":"Li J","year":"2017","unstructured":"J Li, , Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11. Nat Chem Biol 13, 486\u2013493 (2017).","journal-title":"Nat Chem Biol"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncb3289","article-title":"Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis","volume":"18","author":"Guo X","year":"2016","unstructured":"X Guo, , Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis. Nat Cell Biol 18, 202\u2013212 (2016).","journal-title":"Nat Cell Biol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tiv.2017.12.001","article-title":"Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kappaB pathways","volume":"47","author":"Allegra A","year":"2017","unstructured":"A Allegra, , Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kappaB pathways. Toxicol In Vitro 47, 186\u2013194 (2017).","journal-title":"Toxicol In Vitro"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3550609","article-title":"The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: Potential role for DYRK as a glycogen synthase kinase 3-priming kinase","volume":"355","author":"Woods YL","year":"2001","unstructured":"YL Woods, , The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: Potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355, 609\u2013615 (2001).","journal-title":"Biochem J"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.redox.2014.11.002","article-title":"Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma","volume":"4","author":"Salem K","year":"2015","unstructured":"K Salem, ML McCormick, E Wendlandt, F Zhan, A Goel, Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma. Redox Biol 4, 23\u201333 (2015).","journal-title":"Redox Biol"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1806797115","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1806797115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T13:41:43Z","timestamp":1654609303000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1806797115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":40,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2018,8,7]]}},"alternative-id":["10.1073\/pnas.1806797115"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1806797115","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"2018-07-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}